Lamictal

Lamotrigine, the active ingredient in Lamictal, is an anticonvulsant presented as an oral tablet for oral use. It is prescribed to manage seizure disorders and to stabilize mood in bipolar disorder, primarily in adult patients.

GNH USA supplies Lamictal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable, on‑time delivery to meet global healthcare needs, including temperature‑controlled logistics where required. Our network spans Europe, Asia, Africa and the Americas, ensuring broad accessibility.

Lamotrigine is used in the management of seizure disorders and mood stabilization in bipolar disorder.

- Epilepsy: reduces the frequency and severity of seizures in patients with focal or generalized epilepsy. - Bipolar disorder: helps maintain mood stability and prevents recurrence of depressive episodes in adults. - Adjunctive therapy for seizure disorders: used together with other antiepileptic drugs to improve overall seizure control.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis (severe skin reactions) - Aseptic meningitis - Hepatic failure

When prescribing lamotrigine, clinicians should observe several safety measures.

- Titration schedule: initiate at low dose and increase gradually to reduce rash risk. - Skin monitoring: discontinue immediately if severe rash or hypersensitivity develops. - Hepatic impairment: use with caution and monitor liver function tests. - Concomitant valproate: avoid high‑dose combinations; adjust dosing under medical supervision. - Pregnancy and breastfeeding: assess risk‑benefit; consult healthcare provider. - Store below 25°C: keep in the original packaging, protect from moisture and light.

Lamotrigine interacts with several medicines; awareness of the level of interaction is essential.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine plasma concentrations. - Carbamazepine and phenytoin: significantly reduce lamotrigine levels. - Oral contraceptives: lower lamotrigine concentrations, may reduce efficacy.

Moderate Interactions (Monitor Closely): - Other antiepileptic drugs (e.g., phenobarbital): may alter lamotrigine metabolism. - Antidepressants (e.g., SSRIs): potential additive CNS effects. - NSAIDs: may increase risk of skin reactions.